Haptoglobin and Iron in Parkinson's Disease
Status: | Completed |
---|---|
Conditions: | Parkinsons Disease |
Therapuetic Areas: | Neurology |
Healthy: | No |
Age Range: | 35 - 92 |
Updated: | 11/30/2016 |
Start Date: | February 2013 |
End Date: | June 2016 |
Haptoglobin Phenotype and Smoking: Effects on Iron Levels in Parkinson's Disease
This is a case/control epidemiology study to identify what are the iron-metabolism
abnormalities in Parkinson's disease (PD) patients, and risk factors relevant to PD
predisposition.
abnormalities in Parkinson's disease (PD) patients, and risk factors relevant to PD
predisposition.
A total of 342 participants, 100 PD patients and 242 age- and gender matched controls, were
included in the study. All study participants were seen for one study visit in the morning
at one of two Bastyr University Clinics in the Seattle area. Study participants were fasting
at the time of the visit. During the study visit, participants donated a blood sample for
the blood tests and complete an epidemiology questionnaire.
A subset of 51 of the study participant who were seen for the visit at Bastyr University,
underwent brain scan and Magnetic Resonance Imaging (MRI), at the University of Washington
Department of Radiology. The MRI part of the study aims at estimating brain iron levels.
included in the study. All study participants were seen for one study visit in the morning
at one of two Bastyr University Clinics in the Seattle area. Study participants were fasting
at the time of the visit. During the study visit, participants donated a blood sample for
the blood tests and complete an epidemiology questionnaire.
A subset of 51 of the study participant who were seen for the visit at Bastyr University,
underwent brain scan and Magnetic Resonance Imaging (MRI), at the University of Washington
Department of Radiology. The MRI part of the study aims at estimating brain iron levels.
Inclusion Criteria for the Controls, for the blood draw and epidemiology visit:
- Volunteers should be of age between 52 and 82 years of age, males of females.
Exclusion Criteria for the Controls:
- presence of a neurodegenerative disease,
- presence of active cancer under treatment,
- HIV sero-positivity, Hepatitis B, C, of A sero-positivity
- rheumatoid arthritis
- recent blood donation (less than three months before the visit).
- fever at the time of the visit
Inclusion Criteria for the Parkinson's disease patients:
Diagnosis of Parkinson's disease (UKBB clinical criteria).
Exclusion criteria for the Parkinson's disease patients, for the blood draw and
epidemiology visit:
- Presence of other neurodegenerative diseases, apart for Parkinson's disease
- two or more family members with Parkinson's disease
- presence of active cancer under treatment
- HIV sero-positivity, Hepatitis B, C, of A sero-positivity
- rheumatoid arthritis
- recent blood donation (less than three months before the visit).
- fever at the time of the visit
Exclusion criteria for the Magnetic Resonance Imaging:
- presence in the body of a ferro-magnetic metallic foreign object such as, but not
limited to:
- a cardiac pacemaker
- aneurism clip
- neuro-stimulator
- surgical clip
- artificial limb or joint
- orthopedic items, such as screws, nails, pins, rods,
- any metallic foreign body from a previous injury, bullets, shrapnels, metal slivers.
- exclusion criteria for MRI is also the presence of claustrophobia
We found this trial at
3
sites
Univ of Washington Founded in 1861 by a private gift of 10 acres in what...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials